NCT00002945View on ClinicalTrials.gov

High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia

PHASE3CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

December 31, 1996

Primary Completion Date

August 31, 2001

Study Completion Date

August 31, 2011

Conditions
Leukemia
Interventions
BIOLOGICAL

aldesleukin

IV

BIOLOGICAL

filgrastim

IV

DRUG

cyclophosphamide

IV

DRUG

cytarabine

IV

DRUG

etoposide

IV

DRUG

idarubicin

IV

DRUG

melphalan

IV

PROCEDURE

peripheral blood stem cell transplantation

IV

RADIATION

radiation therapy

delivered to the cancer cells

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00002945 - High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter